UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

                         Date of Report: April 27, 2020

                        PURE HARVEST CANNABIS GROUP, INC.
                     ---------------------------------------
                      (Name of registrant as specified in its charter)

                    Colorado        333-212055       71-0952431
                    --------        ----------       ----------
                    State of      Commission File   IRS Employer
                  Incorporation       Number       Identification No.

                          2401 E. 2nd Avenue, Suite 600
                                Denver, CO 80206
                        ---------------------------------
                     Address of principal executive offices

                                 (800) 560-5148
                                ----------------
                      Telephone number, including area code

                 Former name or former address if changed since last report

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications  pursuant to Rule 425 under the Securities Act (17
    CFR 230.425)

[ ] Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17
    CFR 240.14a-12)

[ ] Pre-commencement  communications  pursuant  to Rule  14d-2(b)  under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement  communications  pursuant to Rule  13e-14(c)  under the
    Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the  Registrant is an emerging  growth company as
defined in Rule 405 of the  Securities  Act of 1933 (230.405 of this chapter) or
Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter).

      Emerging Growth Company [x]

If an emerging  growth  company,  indicate by check mark if the  Registrant  has
elected not to use the extended  transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13a of the
Exchange Act. [ ]

Securities registered pursuant to Section 12(b) of the Act:

--------------------------------------------------------------------------------
       Title of each         Trading           Name of each exchange on which
           class            Symbol(s)                    registered
--------------------------------------------------------------------------------

         None                  N/A                         N/A


<PAGE>


Item 1.01   Entry Into a Material Definitive Agreement

   See Item 2.01 of this report.

Item 2.01   Completion of Acquisition or Disposition of Assets

     On April 24, 2020 the Company acquired  substantially  all of the assets of
EdenFlo, LLC, a producer of CBD extracts and concentrates,  for 7,000,000 shares
of the Company's  restricted common stock and the release of their obligation of
a previous promissory note in the amount of $1,650,000.

     EdenFlo  will join  Prolific  Nutrition  and Love Pharm,  LLC to secure and
expand the Company's  position in the national Hemp/CBD  industry.  EdenFlo is a
large-scale  Colorado-based  hemp-CBD  producer and manufacturer of pure isolate
and  full-spectrum  hemp.  EdenFlo's  wholesale isolate is made from the highest
quality ingredients, utilizing only the best extraction and distillation methods
to ensure a final product of extreme purity.  Their  scientific  procedures used
for the remediation of THC provide the cleanest broad-spectrum  (distillate) oil
available in the cannabis extraction  industry.  The acquisition of EdenFlo will
support the  Company's  manufacturing  operations by supplying the Company's raw
materials requirements for its branded products.

     In connection with this  acquisition,  David Burcham,  a member of EdenFlo,
was appointed as the Company's President and as a Director on the Board.

     David Burcham is a Colorado native who left a Senior Management position at
a  prominent  Colorado  bank in 2013 to start  his own real  estate  development
company in the Denver  metro area.  His  business  quickly grew and now oversees
more than 100  residential  and commercial  units.  In July 2018,  David set his
sights on the growing hemp and CBD industry and teamed up with a  well-respected
chemist  and  partner of a small  10-year-old  CBD  extraction  business.  David
transformed the business into an advanced,  pharmaceutical grade, CBD extraction
company and  co-founded  EdenFlo,  LLC  located in Aurora,  CO where he is Chief
Executive Officer.

Item 3.02.  Unregistered Sale of Equity Securities.

     The Company  relied upon the exemption  provided by Section  4(a)(2) of the
Securities  Act of 1933 in  connection  with  sale of the  securities  described
above.  The persons who acquired these securities were  sophisticated  investors
and  were  provided  full  information  regarding  the  Company's  business  and
operations.  There was no general  solicitation  in connection with the offer or
sale of these  securities.  The persons who acquired these  securities  acquired
them for their own accounts. The certificates representing these securities will
bear a restricted  legend  providing that they cannot be sold except pursuant to
an  effective  registration  statement  or an exemption  from  registration.  No
commission  was  paid to any  person  in  connection  with  the  sale  of  these
securities.

Item 5.02.  Departure of Directors or Certain Officers;  Elections of Directors;
            Appointment  of  Certain  Officers;  Compensatory  Arrangements  of
            Certain Officers.

        See Item 2.01 of this report.

<PAGE>


                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  caused  this  report to be signed on its behalf by the  undersigned,
thereunto duly authorized.

April 27, 2020

                                       PURE HARVEST CANNABIS GROUP, INC.

                                       By: /s/ Matthew Gregarek
                                          Matthew Gregarek
                                          Chief Executive Officer
[{"type": "8-K", "sequence": "1", "filename": "form8k101edenflo4-20.txt", "description": "8-K RE. EDENFLO AGREE.", "secsgml_size_bytes": 6548}]
{"company-data": {"conformed-name": "Pure Harvest Cannabis Group, Inc.", "cik": "0001351573", "assigned-sic": "2080", "irs-number": "710952431", "state-of-incorporation": "CO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-212055", "film-number": "20821520"}, "business-address": {"street1": "1624 N. WASHINGTON ST.", "city": "DENVER", "state": "CO", "zip": "80203", "phone": "(800) 560-5148"}, "mail-address": {"street1": "1624 N. WASHINGTON ST.", "city": "DENVER", "state": "CO", "zip": "80203"}, "former-company": [{"former-conformed-name": "Pocket Shot Co", "date-changed": "20160311"}, {"former-conformed-name": "Pocket Shot co", "date-changed": "20060131"}]}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

                         Date of Report: April 27, 2020

                        PURE HARVEST CANNABIS GROUP, INC.
                     ---------------------------------------
                      (Name of registrant as specified in its charter)

                    Colorado        333-212055       71-0952431
                    --------        ----------       ----------
                    State of      Commission File   IRS Employer
                  Incorporation       Number       Identification No.

                          2401 E. 2nd Avenue, Suite 600
                                Denver, CO 80206
                        ---------------------------------
                     Address of principal executive offices

                                 (800) 560-5148
                                ----------------
                      Telephone number, including area code

                 Former name or former address if changed since last report

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications  pursuant to Rule 425 under the Securities Act (17
    CFR 230.425)

[ ] Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17
    CFR 240.14a-12)

[ ] Pre-commencement  communications  pursuant  to Rule  14d-2(b)  under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement  communications  pursuant to Rule  13e-14(c)  under the
    Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the  Registrant is an emerging  growth company as
defined in Rule 405 of the  Securities  Act of 1933 (230.405 of this chapter) or
Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter).

      Emerging Growth Company [x]

If an emerging  growth  company,  indicate by check mark if the  Registrant  has
elected not to use the extended  transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13a of the
Exchange Act. [ ]

Securities registered pursuant to Section 12(b) of the Act:

--------------------------------------------------------------------------------
       Title of each         Trading           Name of each exchange on which
           class            Symbol(s)                    registered
--------------------------------------------------------------------------------

         None                  N/A                         N/A
Item 1.01   Entry Into a Material Definitive Agreement

   See Item 2.01 of this report.

Item 2.01   Completion of Acquisition or Disposition of Assets

     On April 24, 2020 the Company acquired  substantially  all of the assets of
EdenFlo, LLC, a producer of CBD extracts and concentrates,  for 7,000,000 shares
of the Company's  restricted common stock and the release of their obligation of
a previous promissory note in the amount of $1,650,000.

     EdenFlo  will join  Prolific  Nutrition  and Love Pharm,  LLC to secure and
expand the Company's  position in the national Hemp/CBD  industry.  EdenFlo is a
large-scale  Colorado-based  hemp-CBD  producer and manufacturer of pure isolate
and  full-spectrum  hemp.  EdenFlo's  wholesale isolate is made from the highest
quality ingredients, utilizing only the best extraction and distillation methods
to ensure a final product of extreme purity.  Their  scientific  procedures used
for the remediation of THC provide the cleanest broad-spectrum  (distillate) oil
available in the cannabis extraction  industry.  The acquisition of EdenFlo will
support the  Company's  manufacturing  operations by supplying the Company's raw
materials requirements for its branded products.

     In connection with this  acquisition,  David Burcham,  a member of EdenFlo,
was appointed as the Company's President and as a Director on the Board.

     David Burcham is a Colorado native who left a Senior Management position at
a  prominent  Colorado  bank in 2013 to start  his own real  estate  development
company in the Denver  metro area.  His  business  quickly grew and now oversees
more than 100  residential  and commercial  units.  In July 2018,  David set his
sights on the growing hemp and CBD industry and teamed up with a  well-respected
chemist  and  partner of a small  10-year-old  CBD  extraction  business.  David
transformed the business into an advanced,  pharmaceutical grade, CBD extraction
company and  co-founded  EdenFlo,  LLC  located in Aurora,  CO where he is Chief
Executive Officer.

Item 3.02.  Unregistered Sale of Equity Securities.

     The Company  relied upon the exemption  provided by Section  4(a)(2) of the
Securities  Act of 1933 in  connection  with  sale of the  securities  described
above.  The persons who acquired these securities were  sophisticated  investors
and  were  provided  full  information  regarding  the  Company's  business  and
operations.  There was no general  solicitation  in connection with the offer or
sale of these  securities.  The persons who acquired these  securities  acquired
them for their own accounts. The certificates representing these securities will
bear a restricted  legend  providing that they cannot be sold except pursuant to
an  effective  registration  statement  or an exemption  from  registration.  No
commission  was  paid to any  person  in  connection  with  the  sale  of  these
securities.

Item 5.02.  Departure of Directors or Certain Officers;  Elections of Directors;
            Appointment  of  Certain  Officers;  Compensatory  Arrangements  of
            Certain Officers.

        See Item 2.01 of this report.
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  caused  this  report to be signed on its behalf by the  undersigned,
thereunto duly authorized.

April 27, 2020

                                       PURE HARVEST CANNABIS GROUP, INC.

                                       By: /s/ Matthew Gregarek
                                          Matthew Gregarek
                                          Chief Executive Officer